EMA-2023-0022-V122

Type IB variation for application EMA-2023-0022. Type IB variation: Formulation Change for Verasenib — critical change

Variation Number
EMA-2023-0022-V122
Type
Type IB
Application
EMA-2023-0022
Change
CHG-2023-0122
Status
Failed
Fee
€1,095
Submitted
2023-01-30
Approved
—
Description

Type IB variation: Formulation Change for Verasenib — critical change